61
https://pubmed.ncbi.nlm.nih.gov/38095256
Modern surgery for inflammatory bowel disease (IBD) remains an important treatment option, particularly for complications and when medical management fails, with primary surgical resection emerging as a viable alternative to biologics for selected Crohn’s disease patients and offering the only curative option for ulcerative colitis.
